Slingshot members are tracking this event:
FDA Decision Expected By April 5th for Merck's (MRK) Glargine (MK-1293) in Type 1 and Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jul 20, 2017
Related Keywords Glargine, Mk-1293, Type 1 Diabetes, Type 2 Diabetes, Fda, Pdufa